Quantcast AACR Cancer Progress Report 2016

AACR Cancer Progress Report 2016

Saving Lives Through Research


Thanks to research, we are making significant progress against the many diseases we call cancer. One of the most exciting new approaches to cancer treatment is cancer immunotherapy, and the utility of immunotherapy is expanding rapidly.

The AACR Cancer Progress Report 2016 details how federally funded research is fueling the development of new ways to prevent, detect, diagnose, and treat cancer that are saving lives around the world.

  • The number of cancer survivors living in the United States rose by 1 million from 2014 to 2016, reaching an estimated record 15.5 million.
  • Between Aug. 1, 2015, and July 31, 2016, the FDA approved 13 new anticancer therapeutics including four new immunotherapeutics and four new molecularly targeted agents.
  • During the same period, the FDA also approved new uses for 11 previously approved anticancer therapeutics, one new cancer screening test, two new diagnostic imaging agents, and a new medical device for use by women with receiving chemotherapy after a breast cancer diagnosis.

Cancer in 2016

Research improves survival and quality of life for people around the world because it powers the development of new and better ways to prevent, detect, diagnose, treat, and cure some of the many diseases we call cancer.

Preventing Cancer

If we are to prevent cancer from developing, we must understand what causes it.

​Developing Cancer

Changes, or mutations, in the genetic material of normal cells are the primary cause of cancer.

Finding Cancer

There is a need for cancer screening, which can allow us to detect, if present, pre-cancers or cancers at an early stage of development.

Saving Lives Through Research

The dedicated efforts of individuals working throughout the cycle of biomedical research have led to extraordinary advances across the continuum of clinical care that are transforming and saving lives.

Anticipating Future Progress

Only by investing in research talent, tools, and infrastructure; supporting regulatory science initiatives; and increasing patient involvement in precision medicine initiatives, will we be able to accelerate the pace of progress and realize our goal of preventing and curing cancer.


Read inspiring stories of cancer survivors who benefited from basic, translational, clinical, and population science research in the AACR Cancer Progress Report 2016.

FDA Approvals

Learn about recent U.S. Food and Drug Administration approvals of products for cancer prevention, diagnosis, and treatment.

​Read or download the full AACR Cancer Progress Report 2016 on a computer​.

The American Association for Cancer Research (AACR) is a 501c3 registered nonprofit organization with offices at 615 Chestnut Street, 17th Floor, Philadelphia, PA 19106 | 215.440.9300